Cheiron

$8.0M seed

Announced: Jul 22, 2026
Sector: Biotechnology
Investors: 6

Summary

Cheiron raised an $8 million seed round led by Menlo Ventures, with additional backing and strategic support from several industry veterans. The company is building infrastructure to unify drug development knowledge across clinical, regulatory, manufacturing, and commercial functions. Cheiron is a drug development software company.

Investors

Menlo Ventures, Robert Langer, Freda Lewis-Hall, Josh Meier, Laxman Narasimhan, John Giannandrea